Martin McGlynn

2009

In 2009, Martin McGlynn earned a total compensation of $1.3M as President and CEO at StemCells.

Compensation breakdown

Bonus$202,125
Option Awards$132,079
Salary$540,885
Stock Awards$410,667
Other$38,626
Total$1,324,382

McGlynn received $540.9K in salary, accounting for 41% of the total pay in 2009.

McGlynn also received $202.1K in bonus, $132.1K in option awards, $410.7K in stock awards and $38.6K in other compensation.

Rankings

In 2009, Martin McGlynn's compensation ranked 3,558th out of 9,885 executives tracked by ExecPay. In other words, McGlynn earned more than 64.0% of executives.

ClassificationRankingPercentile
All
3,558
out of 9,885
64th
Division
Manufacturing
1,242
out of 3,690
66th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
180
out of 607
70th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
88
out of 331
73rd
Industry
Surgical and Medical Instruments and Apparatus
57
out of 217
74th
Source: SEC filing on April 27, 2012.

McGlynn's colleagues

We found four more compensation records of executives who worked with Martin McGlynn at StemCells in 2009.

2009

Rodney Young

StemCells

Chief Financial Officer

2009

Ann Tsukamoto

StemCells

EVP, Research and Development

2009

Stewart Craig

StemCells

Senior VP, Development and Operations

2009

Ken Stratton

StemCells

General Counsel

You may also like